220
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Evaluating Patient Preferences of Maintenance Therapy for the Treatment of Chronic Obstructive Pulmonary Disease: A Discrete Choice Experiment in the UK, USA and Germany

, ORCID Icon, , , , ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 595-604 | Published online: 18 Mar 2020

References

  • World Health Organization (WHO). Chronic obstructive pulmonary disease (COPD); 2015 http://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Accessed 912, 2018.
  • Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (2019 report); 2019 Available from: https://goldcopd.org/wp-content/uploads/2018/11/GOLD-2019-v1.7-FINAL-14Nov2018-WMS.pdf. Accessed 311, 2019.
  • LipsonDA, BarnhartF, BrealeyN, et al. Once-daily single-inhaler triple versus dual therapy in patients with COPD. N Engl J Med. 2018;378(18):1671–1680. doi:10.1056/NEJMoa171390129668352
  • SinghD, CorradiM, SpinolaM, et al. Triple therapy in COPD: new evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide. Int J Chron Obstruct Pulmon Dis. 2017;12:2917–2928. doi:10.2147/COPD29062229
  • VanfleterenL, FabbriLM, PapiA, PetruzzelliS, CelliB. Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal. Int J Chron Obstruct Pulmon Dis. 2018;13:3971–3981. doi:10.2147/COPD30587953
  • Reed JohnsonF, LancsarE, MarshallD, et al. Constructing experimental designs for discrete-choice experiments: report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force. Value Health. 2013;16(1):3–13. doi:10.1016/j.jval.23337210
  • Pharmaceutical Services Negotiating Committee. Dispensing and supply: what does the patient pay? 2019 Available from: https://psnc.org.uk/dispensing-supply/receiving-a-prescription/patient-charges/. Accessed 1312, 2019.
  • BestallJC, PaulEA, GarrodR, GarnhamR, JonesPW, WedzichaJA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586. doi:10.1136/thx.54.7.58110377201
  • JonesPW, HardingG, BerryP, WiklundI, ChenWH, Kline LeidyN. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.0010250919720809
  • ChoiceMetrics. Ngene: user manual and reference guide; 2018 Available from: http://www.choice-metrics.com/NgeneManual120.pdf. Accessed 531, 2019.
  • TervonenT, Schmidt-OttT, MarshK, BridgesJFP, QuaifeM, JanssenE. Assessing rationality in discrete choice experiments in health: an investigation into the use of dominance tests. Value Health. 2018;21(10):1192–1197. doi:10.1016/j.jval.30314620
  • JanssenEM, MarshallDA, HauberAB, BridgesJFP. Improving the quality of discrete-choice experiments in health: how can we assess validity and reliability? Expert Rev Pharmacoecon Outcomes Res. 2017;17(6):531–542. doi:10.1080/14737167.2017.138964829058478
  • JohnsonFR, YangJ-C, ReedSD. The internal validity of discrete choice experiment data: a testing tool for quantitative assessments. Value Health. 2019;22(2):157–160. doi:10.1016/j.jval.2018.07.87630711059
  • EjioforSI, StolkJ, FernandezP, StockleyRA. Patterns and characterization of COPD exacerbations using real-time data collection. Int J Chron Obstruct Pulmon Dis. 2017;12:427–434. doi:10.2147/COPD.S12615828182151
  • HauberAB, GonzalezJM, Groothuis-OudshoornCG, et al. Statistical methods for the analysis of discrete choice experiments: a report of the ISPOR Conjoint Analysis Good Research Practices Task Force. Value Health. 2016;19(4):300–315. doi:10.1016/j.jval.2016.04.00427325321
  • BridgesJ, HauberA, MarshallD, et al. Conjoint analysis applications in health–a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force. Value Health. 2011;14(4):403–413. doi:10.1016/j.jval.2010.11.01321669364
  • JanssenEM, SegalJB, BridgesJF. A framework for instrument development of a choice experiment: an application to type 2 diabetes. Patient. 2016;9(5):465–479. doi:10.1007/s40271-016-0170-327120338
  • HalbertRJ, NatoliJL, GanoA, BadamgaravE, BuistAS, ManninoDM. Global burden of COPD: systematic review and meta-analysis. Eur Respir J. 2006;28(3):523–532. doi:10.1183/09031936.06.0012460516611654
  • VarmaghaniM, DehghaniM, HeidariE, SharifiF, MoghaddamSS, FarzadfarF. Global prevalence of chronic obstructive pulmonary disease: systematic review and meta-analysis. East Mediterr Health J. 2019;25(1):47–57.30919925
  • ValenteS, PasciutoG, BernabeiR, CorboGM. Do we need different treatments for very elderly COPD patients? Respiration. 2010;80(5):357–368. doi:10.1159/00032022120733280